[Significance in therapy: beta-sympathomimetics in bronchial asthma].
Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität, Am Hubland, 97074 Würzburg. hogger@pzlc.uni-wuerzburg.de
Petra
P
Högger
D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D004359:Drug Therapy, Combination; D017408:Guidelines as Topic; D006801:Humans; D008134:Long-Term Care; D011110:Polymorphism, Genetic / Q000235:genetics; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D018343:Receptors, Adrenergic, beta-2